Organon & Co (NYSE:OGN) currently has a daily average trading volume of 5.69M but it saw 3810355 shares traded in last market. With a market cap of 2.60B USD, the company’s current market price of $10.02 came rising about 1.11 while comparing to the previous closing price of $9.91. In past 52 weeks, the stock remained buoying in the range of price level as high as $23.10 and as low as $8.01. In the recent trading on the day, stock has struck highest price mark of $9.845 while lowest mark touched by it was $10.12.
JP Morgan downgraded its recommendation for the stock as a “Underweight” from “Neutral” on September 06, 2024 while assigning a price target range of $18-$20. Goldman also issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $33 and $16.
Over the week, OGN’s stock price is moving -1.28% down while it is 2.66% when we observe its performance for the past one month. Year-to-date it is -50.25% down and over the past year, the stock is showing a downside performance of -32.84%.
The company is expected to be releasing its next quarterly report on 2025-May-01, for which analysts forecasted an EPS of 0.94 while estimate for next year EPS is 3.86. In next quarter, company is expected to be making quarterly sales of $1.56B as analysts are expecting the sales for current fiscal year at $6.22B and seeing the company making $6.29B in sales next year. Moreover, analysts are in estimates of $1.55B for current-quarter revenue.
Currently, Organon & Co’s total number of outstanding shares is 259.96M with 0.24% of that held by the insiders while 80.89% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 7.91% and return on equity (ROE) at 254.24%. It has a price to earnings ratio (P/E ratio) of 3.47 while having a 2.44 of forward P/E ratio. Stock’s beta reads 0.56. Stock has a price to book (P/B) ratio of 4.77 while price to sale or P/S ratio amounts to 0.41. Its return on asset (ROA) is 5.99% on average.
